Skip to main content
Clinical Trials/RPCEC00000400
RPCEC00000400
Completed
未知

Validation study for the clinical use of the Hipermax BF automatic blood pressure measurement device in the general population. - VALIDAC HIPERMAX-BF

Institute of Cardiology and Cardiovascular Surgery (ICCCV)0 sites85 target enrollmentFebruary 4, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Arterial hypertension
Sponsor
Institute of Cardiology and Cardiovascular Surgery (ICCCV)
Enrollment
85
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 4, 2022
End Date
March 15, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institute of Cardiology and Cardiovascular Surgery (ICCCV)

Eligibility Criteria

Inclusion Criteria

  • 1\. In all cases, informed consent will be obtained.
  • 2\. Age 12 years or older, not pregnant
  • 3\. No arrhythmias (Electrocardiogram)
  • 4\. Blood pressure in the SBP 80\-220 mmHg and DBP 50\-120 mmHg ranges (Initial blood pressure measurement)

Exclusion Criteria

  • 1\. Refusal to be part of the study.
  • 2\. Belonging to a group classified as a special population: children under 12 years of age or pregnant women.
  • 3\. K5 Korotkoff sound not audible in one subject.
  • 4\. Cardiac arrhythmias

Outcomes

Primary Outcomes

Not specified

Similar Trials